Spectrum Pharmaceuticals, Inc. Shares Near 52-Week Low - Market Mover
The shares closed 0.9% above its 52-week low of $1.15, with trading volume higher than its 30 day average
Jan 09, 2022 by Kwhen Finance Editors
Spectrum Pharmaceuticals, Inc. (SPPI) shares closed today at 0.9% above its 52 week low of $1.15, giving the company a market cap of $190M. The stock is currently down 8.7% year-to-date, down 69.1% over the past 12 months, and down 75.9% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 58.4% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.6.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Spectrum Pharmaceuticals, Inc. | -4.9 | -8.7 | -69.1 | -73.6 | 4.3 |
| Dow Jones Industrial Average | -0.0 | -0.3 | 18.7 | -2.0 | 23.2 |
| S&P 500 Index | -0.4 | -1.9 | 24.6 | -2.5 | 28.8 |
| Health Care | -0.7 | -5.2 | 13.5 | -5.5 | 21.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 182.8%
- The company's stock price performance over the past 12 months lags the peer average by -6639.5%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Spectrum Pharmaceuticals, Inc. | SPPI | 0 | -8.7 | -69.1 | -73.6 | 4.3 |
| Peer Avg | N/A | 5.2 | -3.1 | 1.1 | -23.1 | 21.7 |
| Johnson & Johnson | JNJ | 25.6 | 1.7 | 11.2 | -3.5 | 15.4 |
| Pfizer Inc. | PFE | 16.3 | -5.6 | 56.2 | -10.3 | 70.6 |
| Abbott Laboratories | ABT | 33.1 | -3.7 | 23.7 | -5.4 | 29.0 |
| Novartis AG - ADR | NVS | 37.7 | 2.1 | -0.5 | -7.0 | 11.6 |
| Bristol-Myers Squibb Co. | BMY | -25.8 | 1.7 | 4.0 | -10.3 | 16.6 |
| Glaxosmithkline plc - ADR | GSK | 17.0 | -0.6 | 21.8 | -2.2 | 35.1 |
| Biogen Inc | BIIB | 22.1 | -3.1 | -7.1 | -49.7 | 6.2 |
| Seagen Inc | SGEN | -79.0 | -7.0 | -18.5 | -27.5 | 8.3 |
| Teva- Pharmaceutical Industries Ltd. - ADR | TEVA | 13.4 | 10.5 | -20.1 | -35.9 | 10.2 |
| Curis Inc | CRIS | -8.1 | -26.6 | -60.2 | -79.1 | 14.5 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: